Records containing: Hyperargininemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-24An Open-label, Multicentre Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of AEB1102 in Patients With Arginase 1 Deficiency
-
CLINICAL_TRIALS study record update · 2026-04-27Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders
-
CLINICAL_TRIALS study record update · 2025-07-20Hepatic Histopathology in Urea Cycle Disorders
-
CLINICAL_TRIALS study record update · 2025-04-17Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders
-
CLINICAL_TRIALS study record update · 2025-04-04Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-19PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
-
CLINICAL_TRIALS study record update · 2023-07-27A Phase 3 Open-Label Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency
-
CLINICAL_TRIALS study record update · 2023-07-27An Open-label, Multicentre Extension Study to Evaluate the Long-Term Safety, Tolerability and Effects of Intravenous AEB1102 in Patients With Arginase I Deficiency Who Previously Received Treatment in Study CAEB1102-101A
-
CLINICAL_TRIALS study record update · 2019-12-09The NIH UNI Study: Urea Cycle Disorders, Nutrition and Immunity
-
CLINICAL_TRIALS study record update · 2019-06-12A Phase 1/2 Open-label Study in Patients With Arginase I Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous AEB1102